Jan G. Klijn - Publications

Loss of E-cadherin is not a necessity for epithelial to mesenchymal transition in human breast cancer.

Journal: Breast cancer research and treatment

Published: November 06, 2012

Differences in natural history between breast cancers in BRCA1 and BRCA2 mutation carriers and effects of MRI screening-MRISC, MARIBS, and Canadian studies combined.

Journal: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

Published: June 30, 2012

Correlation of breast cancer susceptibility loci with patient characteristics, metastasis-free survival, and mRNA expression of the nearest genes.

Journal: Breast cancer research and treatment

Published: April 06, 2011

Gene expression profiling assigns CHEK2 1100delC breast cancers to the luminal intrinsic subtypes.

Journal: Breast cancer research and treatment

Published: March 03, 2011

BRCA1-associated breast cancers present differently from BRCA2-associated and familial cases: long-term follow-up of the Dutch MRISC Screening Study.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: November 17, 2010

Randomized phase II study comparing efficacy and safety of combination-therapy trastuzumab and docetaxel vs. sequential therapy of trastuzumab followed by docetaxel alone at progression as first-line chemotherapy in patients with HER2+ metastatic breast cancer: HERTAX trial.

Journal: Clinical breast cancer

Published: April 08, 2010

Early diagnosis of hereditary breast cancer by magnetic resonance imaging: what is realistic?

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: February 24, 2010

Increased MUTYH mutation frequency among Dutch families with breast cancer and colorectal cancer.

Journal: Breast cancer research and treatment

Published: November 27, 2009

Association of rare MSH6 variants with familial breast cancer.

Journal: Breast cancer research and treatment

Published: September 08, 2009

Four human breast cancer cell lines with biallelic inactivating alpha-catenin gene mutations.

Journal: Breast cancer research and treatment

Published: July 10, 2009

Sensitivity to first-line chemotherapy for metastatic breast cancer in BRCA1 and BRCA2 mutation carriers.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: July 01, 2009

Distinct gene mutation profiles among luminal-type and basal-type breast cancer cell lines.

Journal: Breast cancer research and treatment

Published: June 25, 2009